ADVANCED REFRACTORY SOLID TUMORS
Clinical trials for ADVANCED REFRACTORY SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED REFRACTORY SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED REFRACTORY SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double attack on EGFR-Positive tumors: targeted drug plus immunotherapy combo tested
Disease control Recruiting nowThis phase II trial tests a combination of two drugs—becotatug vedotin, which targets cancer cells with high levels of EGFR, and pucotenlimab, which helps the immune system attack tumors—in people with advanced solid tumors that have not responded to standard treatments. The stud…
Matched conditions: ADVANCED REFRACTORY SOLID TUMORS
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Cancer-Killing virus trial launches for patients out of options
Disease control Recruiting nowThis study tests a new treatment called GO306, a modified virus designed to infect and destroy cancer cells. It is for adults with advanced solid tumors (like breast, colon, or kidney cancer) that have not responded to standard therapies. The main goal is to check the safety of t…
Matched conditions: ADVANCED REFRACTORY SOLID TUMORS
Phase: PHASE1 • Sponsor: GeneSail Biotech (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC